183 related articles for article (PubMed ID: 8239580)
1. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.
Yasuda H; Ajiki Y; Koga T; Kawada H; Yokota T
Antimicrob Agents Chemother; 1993 Sep; 37(9):1749-55. PubMed ID: 8239580
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of biofilm formation by clarithromycin (CAM) in an experimental model of complicated bladder infection--in vitro study using automated simulation of urinary antimicrobial concentration].
Sano M; Kumamoto Y; Nishimura M; Tsukamoto T; Hirose T; Ohya S
Kansenshogaku Zasshi; 1994 Nov; 68(11):1306-17. PubMed ID: 7829898
[TBL] [Abstract][Full Text] [Related]
3. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis.
Kandemir O; Oztuna V; Milcan A; Bayramoğlu A; Celik HH; Bayarslan C; Kaya A
Clin Orthop Relat Res; 2005 Jan; (430):171-5. PubMed ID: 15662320
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
Kondoh K; Hashiba M
Nihon Jibiinkoka Gakkai Kaiho; 1998 Jan; 101(1):25-36. PubMed ID: 9493436
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
Elkhatib W; Noreddin A
Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
[TBL] [Abstract][Full Text] [Related]
6. Effect of clarithromycin on Pseudomonas aeruginosa biofilms.
Tanaka G; Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T
Chemotherapy; 2000; 46(1):36-42. PubMed ID: 10601796
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa.
Kondoh K; Hashiba M; Baba S
Acta Otolaryngol Suppl; 1996; 525():56-60. PubMed ID: 8908271
[TBL] [Abstract][Full Text] [Related]
8. Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model.
Yanagihara K; Tomono K; Imamura Y; Kaneko Y; Kuroki M; Sawai T; Miyazaki Y; Hirakata Y; Mukae H; Kadota J; Kohno S
J Antimicrob Chemother; 2002 May; 49(5):867-70. PubMed ID: 12003986
[TBL] [Abstract][Full Text] [Related]
9. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
Cirioni O; Ghiselli R; Silvestri C; Minardi D; Gabrielli E; Orlando F; Rimini M; Brescini L; Muzzonigro G; Guerrieri M; Giacometti A
J Antimicrob Chemother; 2011 Jun; 66(6):1318-23. PubMed ID: 21406436
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
11. Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis.
Yasuda H; Ajiki Y; Koga T; Yokota T
Antimicrob Agents Chemother; 1994 Jan; 38(1):138-41. PubMed ID: 8141568
[TBL] [Abstract][Full Text] [Related]
12. [Interaction between biofilm formed by Pseudomonas aeruginosa and antibacterial agents].
Feng X; Zhao G; Cui L; Guan X; Wang H
Wei Sheng Wu Xue Bao; 2000 Apr; 40(2):210-3. PubMed ID: 12548947
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains.
Kádár B; Szász M; Kristóf K; Pesti N; Krizsán G; Szentandrássy J; Rókusz L; Nagy K; Szabó D
Acta Microbiol Immunol Hung; 2010 Sep; 57(3):235-45. PubMed ID: 20870595
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa.
Ishida H; Ishida Y; Kurosaka Y; Otani T; Sato K; Kobayashi H
Antimicrob Agents Chemother; 1998 Jul; 42(7):1641-5. PubMed ID: 9660997
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.
Bui KQ; Banevicius MA; Nightingale CH; Quintiliani R; Nicolau DP
J Antimicrob Chemother; 2000 Jan; 45(1):57-62. PubMed ID: 10629013
[TBL] [Abstract][Full Text] [Related]
16. [Quantitative evaluation of the inhibitory action of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
Kondo K; Hashiba M; Baba S
Jpn J Antibiot; 1997 Mar; 50 Suppl A():102-5. PubMed ID: 9597456
[No Abstract] [Full Text] [Related]
17. Bacterial biofilm in chronic airway infection.
Ohgaki N
Kansenshogaku Zasshi; 1994 Jan; 68(1):138-51. PubMed ID: 8138670
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation.
Yanagihara K; Tomono K; Sawai T; Kuroki M; Kaneko Y; Ohno H; Higashiyama Y; Miyazaki Y; Hirakata Y; Maesaki S; Kadota J; Tashiro T; Kohno S
J Antimicrob Chemother; 2000 Jul; 46(1):69-72. PubMed ID: 10882691
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
Li Y; Huang J; Li L; Liu L
Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
